91 related articles for article (PubMed ID: 1818953)
1. Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177.
Sechi LA; Grady EF; Griffin CA; Kalinyak JE; Schambelan M
J Hypertens Suppl; 1991 Dec; 9(6):S224-5. PubMed ID: 1818953
[No Abstract] [Full Text] [Related]
2. Characterization of glomerular angiotensin II receptor subtypes.
Gauquelin G; Garcia R
Receptor; 1992; 2(3):207-12. PubMed ID: 1472951
[TBL] [Abstract][Full Text] [Related]
3. Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.
Cogan MG; Liu FY; Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Nov; 259(2):687-91. PubMed ID: 1941617
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor subtypes in bovine and human ventricular myocardium.
Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Yamada S; Inabe K; Kimura R; Suzuki H; Hoshino T
J Pharmacol Exp Ther; 1994 Aug; 270(2):566-71. PubMed ID: 8071849
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and identification of a novel tetrazole metabolite of the angiotensin II receptor antagonist DuP 753.
Stearns RA; Doss GA; Miller RR; Chiu SH
Drug Metab Dispos; 1991; 19(6):1160-2. PubMed ID: 1687025
[No Abstract] [Full Text] [Related]
6. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
Chang RS; Lotti VJ
Mol Pharmacol; 1990 Mar; 37(3):347-51. PubMed ID: 2314387
[TBL] [Abstract][Full Text] [Related]
7. [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Jul; 38(7):471-6. PubMed ID: 8221742
[TBL] [Abstract][Full Text] [Related]
8. Distribution of angiotensin II receptor subtypes in rat and human kidney.
Sechi LA; Grady EF; Griffin CA; Kalinyak JE; Schambelan M
Am J Physiol; 1992 Feb; 262(2 Pt 2):F236-40. PubMed ID: 1539685
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
10. Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature.
Zhuo J; Dean R; MacGregor D; Alcorn D; Mendelsohn FA
Clin Exp Pharmacol Physiol Suppl; 1996; 3():S147-54. PubMed ID: 8993855
[TBL] [Abstract][Full Text] [Related]
11. Identification of AT1 receptors on human platelets and decreased angiotensin II binding in hypertension.
Crabos M; Bertschin S; Bühler FR; Rogg H; Evéquoz D; Eberhard M; Erne P
J Hypertens Suppl; 1993 Dec; 11(5):S230-1. PubMed ID: 8158359
[No Abstract] [Full Text] [Related]
12. Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists.
Regitz-Zagrosek V; Auch-Schwelk W; Hess B; Klein U; Duske E; Steffen C; Hildebrandt AG; Fleck E
J Cardiovasc Pharmacol; 1995 Jul; 26(1):66-72. PubMed ID: 7564368
[TBL] [Abstract][Full Text] [Related]
13. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
[No Abstract] [Full Text] [Related]
15. DuP 753 can antagonize the effects of angiotensin II in rat liver.
Bauer PH; Chiu AT; Garrison JC
Mol Pharmacol; 1991 Apr; 39(4):579-85. PubMed ID: 2017158
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function.
Tsutsumi K; Saavedra JM
Endocrinology; 1991 Dec; 129(6):3001-8. PubMed ID: 1954884
[TBL] [Abstract][Full Text] [Related]
17. Characterization of putative glomerular receptors for angiotensin II in the rainbow trout Oncorhynchus mykiss using the antagonists Losartan, PD 123177, and saralasin.
Cobb CS; Brown JA
Gen Comp Endocrinol; 1993 Oct; 92(1):123-31. PubMed ID: 8262354
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with angiotensin II receptor antagonists.
Lee RJ; Brunner HR
J Hum Hypertens; 1993 Aug; 7 Suppl 2():S33-6. PubMed ID: 8230087
[TBL] [Abstract][Full Text] [Related]
19. N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans.
Huskey SE; Miller RR; Chiu SH
Drug Metab Dispos; 1993; 21(5):792-9. PubMed ID: 7902238
[TBL] [Abstract][Full Text] [Related]
20. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
Wong PC; Timmermans PB
Blood Press Suppl; 1996; 3():11-4. PubMed ID: 8973760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
